TUB-030, a novel ADC targeting 5T4: A phase I/IIa multi-center, first-in-human clinical trial (5-STAR 1-01) in patients with advanced solid tumors.

Authors: Shiraj Sen, Sheena Sahota, Lillian L. Siu, Thomas Urban Marron, Candace L. Haddox, Patricia LoRusso, Daniel Morgensztern, Andrea Elisabeth Wahner Hendrickson, Jaime R. Merchan, Katharina Heinzelmann, Björn M Hock, Guenter Fingerle-Rowson, Yariv J. Houvras, Anthony W. Tolcher

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3164

Source: Full article

---

Abstract

TPS3164